Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.

Elon Musk’s Neuralink has said it’s about to begin testing a technology that could enable someone with paralysis to control a robotic arm with their thoughts.

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control using the N1 implant to an investigational assistive robotic arm," adding that it is "an important first step towards restoring not only digital freedom, but also physical freedom."

Specializing in neurotechnologies, the American startup Neuralink has already made a name for itself by implanting a chip in a patient's brain, enabling them to interact with a computer by thought alone.

Elon Musk's Neuralink received approval to launch a new feasibility trial using its brain implant and an investigational assistive robotic arm, the brain-chip startup said in a post on X on Monday.

US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic arm. Founded by Elon Musk, the company said that the trial, named CONVOY, will operate with cross-enrolling from the company’s ongoing PRIME study (NCT06429735), which is being completed in the US.

Elon Musk's brain-computer interface (BCI) company is entering its next phase of experiments: seeing if patients can move a robotic arm using their minds. In a statement posted on Musk's "everything app,

Neuralink, a brain technology start-up founded by Elon Musk, has received approval to commence a feasibility study involving its brain implant and an experimental robotic arm, the South China Morning Post reported. The PRIME study will evaluate the safety of Neuralink's wireless brain-computer interface and surgical robot.